Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling
Mélissa Alame, Emmanuel Cornillot, Valère Cacheux, et al.
Theranostics (2021) Vol. 11, Iss. 8, pp. 3565-3579
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1720-1748
Open Access | Times Cited: 2250
Molecular and clinical diversity in primary central nervous system lymphoma
Isaias Hernández-Verdín, E. Kirasic, Kirsty Wienand, et al.
Annals of Oncology (2022) Vol. 34, Iss. 2, pp. 186-199
Open Access | Times Cited: 51
Regulatory T cells promote functional recovery after spinal cord injury by alleviating microglia inflammation via STAT3 inhibition
Rui Liu, Ying Li, Ziyue Wang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2129-2144
Open Access | Times Cited: 25
Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts
Katrin S. Kurz, Michaela Ott, Sabrina Kalmbach, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2285-2285
Open Access | Times Cited: 17
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
Michael Heming, Svea Haessner, Jolien Wolbert, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 23
The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma
Julia C. Kuehn, Nicolas Neidert, Junyi Zhang, et al.
Leukemia (2025)
Open Access
Optoresponsive Pheophorbide-Silver based organometallic nanomaterials for high efficacy multimodal theranostics in Melanoma
Prathamesh Patil, Nidhi Poddar, Nidhi Parihar, et al.
Chemical Engineering Journal (2023) Vol. 470, pp. 144110-144110
Closed Access | Times Cited: 11
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma
Chuanwei Yang, Xiaohui Ren, Yong Cui, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma
Nianping Liu, Chen Jiang, Xinfeng Yao, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis
Han Shi, Xuefei Sun, Yuchen Wu, et al.
Journal of Clinical Neuroscience (2024) Vol. 124, pp. 36-46
Closed Access | Times Cited: 3
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
Zhiyong Zeng, Apeng Yang, Jingke Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma
Zhiguang Lin, Jingjing Ma, Yan Ma, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Updates of primary central nervous system lymphoma
Jiaying Wu, Delian Zhou, Xiaojian Zhu, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 2
Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
Marion Alcantara, Jaime R. Fuentealba, Carole Soussain
Cancers (2021) Vol. 13, Iss. 20, pp. 5061-5061
Open Access | Times Cited: 17
Extranodal lymphoma: pathogenesis, diagnosis and treatment
Hua Yang, Yang Xun, Chao Ke, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 6
Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
Hyun Hee Koh, Sang Eun Yoon, Seok Jin Kim, et al.
Cancer Medicine (2023) Vol. 12, Iss. 19, pp. 19732-19743
Open Access | Times Cited: 5
Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis
Haotian Liu, Qiuying Dai, Yixian Li, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study
Danqing Zhao, Yan Zhang, Wenjia Zhu, et al.
Annals of Hematology (2023) Vol. 103, Iss. 2, pp. 545-552
Closed Access | Times Cited: 4
Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
Linlin Jiang, Peng Wang, Mu Su, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
Margaretha G.M. Roemer, Tim van de Brug, Erik Bosch, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107331-107331
Open Access | Times Cited: 3
Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B‐cell lymphoma
Adnan Mansoor, Ariz Akhter, Meer‐Taher Shabani‐Rad, et al.
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 828-837
Open Access | Times Cited: 2
Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics
Keir Pickard, Emily Stephenson, Alex Mitchell, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies
Isaias Hernández-Verdín, Andrea Morales-Martínez, Khê Hoang‐Xuan, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 6, pp. 779-786
Open Access | Times Cited: 4
CLINICAL MANIFESTATIONS OF DIFFUSE LARGE B CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM
P.P. Bessonov, N.G. Bessonova, M.S. Alekseeva, et al.
Современные проблемы науки и образования (Modern Problems of Science and Education) (2024), Iss. №2 2024, pp. 90-90
Open Access
Metallic nanoparticles for photodynamic cancer therapy
Rafquat Rana, Keerti Mishra, Shourya Tripathi, et al.
Elsevier eBooks (2024), pp. 301-326
Closed Access
Page 1 - Next Page

Scroll to top